CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology Genetics Investing
Applied DNA Sciences Provides Farm-to-Finished Goods Traceability in Long Term Arrangement with Key US Retailer Medical Device Investing
Cellular Biomedicine Group Announces Three-Month Interim Safety Data from Phase I Clinical Trial for AlloJoin™ Off-the-Shelf Allogeneic Stem Cell Therapy Genetics Investing
Myriad Genetics' EndoPredict® Test Significantly Outperforms the First-Generation Test in Predicting the Risk of Node-Negative and Node-Positive Breast Cancer Recurrence Medical Device Investing
Genomic Health Announces Results from Multiple Oncotype DX® Studies for Breast Cancer Genetics Investing